4//SEC Filing
Sharp John P 4
Accession 0001209191-19-047182
CIK 0001169245other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 7:42 PM ET
Size
11.4 KB
Accession
0001209191-19-047182
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2019-08-21−5,000→ 4,038 totalExercise: $1.44Exp: 2027-04-21→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2019-08-21$1.69/sh+10,000$16,900→ 30,000 total - Exercise/Conversion
Common Stock
2019-08-21$1.44/sh+5,000$7,200→ 35,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-08-21−10,000→ 110,582 totalExercise: $1.69Exp: 2026-05-12→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option shall vest on April 11, 2017, the first anniversary of the Vesting Commencement Date, and the remainder of the shares subject to the option shall vest in equal monthly installments over 36 months on the same day of the month as the Vesting Commencement Date, subject to the reporting person's continued service through each such date. The vesting schedule for this option was incorrectly reported in a prior filing due to a clerical error.
- [F2]The shares subject to the option shall vest in equal monthly installments over 48 months from March 1, 2017, subject to the reporting person's continued service through each such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001342894
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 7:42 PM ET
- Size
- 11.4 KB